uHTS IMPLEMENTATION CORE General Facility Description. Occupying -1500 ft2 of space, the uHTS core provides state-of-the-art environmental controls to maintain humidity, temperature and air-borne particulate to a class 10,000 clean room standard. Within 100 feet of the this facility is an additional 350 ft2 of laboratory space used for reagent preparation and consumables storage. The uHTS core is subdivided into 3 laboratories: (1) uHTS assay adaptation/implementation laboratory, (2) uHTS platform laboratory and (3) the compound management laboratory. To facilitate efficient use of resources, relevant capital equipment is shared between the laboratories. 1. The uHTS Implementation Laboratory This laboratory, located within the clean room facility and adjacent to the uHTS platform, contains capital equipment to facilitate

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MH084512-06
Application #
8525453
Study Section
Special Emphasis Panel (ZRG1-BCMB-D)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
6
Fiscal Year
2013
Total Cost
$1,824,602
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Penas, Clara; Ramachandran, Vimal; Simanski, Scott et al. (2014) Casein kinase 1?-dependent Wee1 protein degradation. J Biol Chem 289:18893-903
Chang, Mi Ra; Lyda, Brent; Kamenecka, Theodore M et al. (2014) Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor ? is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatol 66:579-88
Yan, Fei; Yu, Yang; Chow, Dar-Chone et al. (2014) Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor. PLoS One 9:e95243
Sarkisyan, Gor; Gay, Laurie J; Nguyen, Nhan et al. (2014) Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth. Am J Physiol Cell Physiol 307:C14-24
Lewallen, Daniel M; Bicker, Kevin L; Madoux, Franck et al. (2014) A FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs. ACS Chem Biol 9:913-21
Lewallen, Daniel M; Sreelatha, Anju; Dharmarajan, Venkatasubramanian et al. (2014) Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation. ACS Chem Biol 9:433-42
Gentry, Patrick R; Kokubo, Masaya; Bridges, Thomas M et al. (2014) Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380). J Med Chem 57:7804-10
Yun, Bogeon; Lee, HeeJung; Ghosh, Moumita et al. (2014) Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation. J Biol Chem 289:1491-504
Niphakis, Micah J; Cravatt, Benjamin F (2014) Enzyme inhibitor discovery by activity-based protein profiling. Annu Rev Biochem 83:341-77
Dreyton, Christina J; Anderson, Erin D; Subramanian, Venkataraman et al. (2014) Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation. Bioorg Med Chem 22:1362-9

Showing the most recent 10 out of 80 publications